Triple

T10214621
Position Surface form Disambiguated ID Type / Status
Subject Renflexis E242409 entity
Predicate hasReferenceProduct P62838 FINISHED
Object Remicade E49851 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Remicade | Statement: [Renflexis, hasReferenceProduct, Remicade]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Remicade
Context triple: [Renflexis, hasReferenceProduct, Remicade]
  • A. Remicade chosen
    Remicade is a widely used monoclonal antibody biologic (infliximab) prescribed to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
  • B. Humira
    Humira is a widely used biologic medication (adalimumab) that treats various autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease by inhibiting tumor necrosis factor (TNF).
  • C. Stelara
    Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
  • D. Kevzara
    Kevzara is a prescription monoclonal antibody medication (sarilumab) used to treat adults with moderate to severe rheumatoid arthritis by targeting the interleukin-6 (IL-6) receptor.
  • E. Rituxan
    Rituxan is a monoclonal antibody drug (rituximab) widely used to treat certain blood cancers and autoimmune diseases by targeting the CD20 protein on B cells.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: hasReferenceProduct
Context triple: [Renflexis, hasReferenceProduct, Remicade]
  • A. hasProduct
    Indicates that an entity possesses, offers, or is associated with a particular product.
  • B. hasRetailProduct
    Indicates that an entity offers, sells, or makes available a particular product in a retail context.
  • C. hasReferenceWork
    Indicates that one entity is associated with a reference work (such as a dictionary, encyclopedia, or manual) that provides authoritative information about it.
  • D. byProduct
    Indicates that one entity is produced incidentally or as a secondary result of a process, activity, or creation involving another entity.
  • E. relatedToProduct chosen
    Indicates a general association or connection between an entity and a specific product, without specifying the exact nature of that relationship.
  • F. None of above.

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d381ae26c48190985abd0e25ee5d04 completed April 6, 2026, 9:49 a.m.
NER Named-entity recognition batch_69d3aa273bdc8190bc4cf67a7923cebc completed April 6, 2026, 12:42 p.m.
NED1 Entity disambiguation (via context triple) batch_69d89f25c16c8190a17dc19e3e1b197a completed April 10, 2026, 6:56 a.m.
PD Predicate disambiguation batch_69d39559e5ac8190b88eca75956b7e6a completed April 6, 2026, 11:13 a.m.
Created at: April 6, 2026, 11:04 a.m.